MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Colleagues,

As reported in Genome Web News ... Agilent Technologies has inked a definitive agreement to acquire Varian for $52 per share, or a total of around $1.5 billion.

The deal will expand Agilent's presence in the life sciences research and applied markets, such as the environment and energy. Agilent said that it also will expand its product portfolio into atomic and molecular spectroscopy and in other fields including nuclear magnetic resonance, imaging, and vacuum technologies....

Read on at: http://www.genomeweb.com//node/921080?emc=el&m=450755&l=1&a...

ENJOY!

CC

Views: 2

© 2024   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service